Literature DB >> 12791201

Galactosemia.

Pamela H. Arn1.   

Abstract

Despite the dramatic response of sick neonates with galactosemia to the withdrawal of galactose from the diet, over the long-term, complications, including learning disorders, verbal apraxia, and ataxia, often develop. It is clear that, although lifelong galactose restriction remains the basis of treatment for this disease, additional treatment methods are needed. The neurologist familiar with galactosemia can assist in diagnosis of neonates presenting with central nervous system symptoms. Familiarity with the long-term neurologic consequences of galactosemia can help the neurologist assist the family with prognostic information and to avoid unnecessary tests when complications occur.

Entities:  

Year:  2003        PMID: 12791201     DOI: 10.1007/s11940-003-0040-x

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  14 in total

1.  Verbal dyspraxia in children with galactosemia.

Authors:  D Nelson
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 2.  Galactosaemia: pathogenesis and treatment.

Authors:  J B Holton
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

3.  Sepsis due to Escherichia coli in neonates with galactosemia.

Authors:  H L Levy; S J Sepe; V E Shih; G F Vawter; J O Klein
Journal:  N Engl J Med       Date:  1977-10-13       Impact factor: 91.245

4.  Galactosaemia: relationship of IQ to biochemical control and genotype.

Authors:  M A Cleary; L E Heptinstall; J E Wraith; J H Walter
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Risk factors for premature ovarian failure in females with galactosemia.

Authors:  N V Guerrero; R H Singh; A Manatunga; G T Berry; R D Steiner; L J Elsas
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

6.  A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine.

Authors:  F R Manis; L B Cohn; C McBride-Chang; J A Wolff; F R Kaufman
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

7.  Computed tomographic demonstration of cerebral edema in a child with galactosemia.

Authors:  A L Belman; S L Moshe; R D Zimmerman
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

8.  Curious neurologic sequelae in galactosemia.

Authors:  W Lo; S Packman; S Nash; K Schmidt; S Ireland; I Diamond; W Ng; G Donnell
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

9.  Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia.

Authors:  G T Berry; I Nissim; Z Lin; A T Mazur; J B Gibson; S Segal
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

Review 10.  The molecular biology of galactosemia.

Authors:  L J Elsas; K Lai
Journal:  Genet Med       Date:  1998 Nov-Dec       Impact factor: 8.822

View more
  1 in total

1.  Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE).

Authors:  Jane Odhiambo Mumma; Juliet S Chhay; Kerry L Ross; Jana S Eaton; Karen A Newell-Litwa; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.